• FDA Rejects Regeneron Pharmaceuticals, Inc. (REGN)'s Arcalyst for Gout More...
• Arena Pharmaceuticals, Inc. (ARNA) Transfers Diet Pill Application to Eisai Company, Ltd. (ESALY.PK) More...
• FDA Accepts NuPathe Inc. (PATH)'s Migraine Patch NDA Resubmission for Filing More...
• Ariad Pharmaceuticals, Inc. (ARIA) Announces Submission of New Drug Application for Ponatinib to the FDA More...
• Vertex Pharmaceuticals Incorporated (VRTX) Lowers Incivek View; New Drug Data Lifts Shares More...
• Nymox Pharmaceutical (NYMX) Reports Positive Results From Combined Statistical Analysis of Long Term Follow-Up Studies of BPH Drug More...
• Rockwell Medical Technologies (RMTI) Completes Patient Enrollment in Phase III Clinical Trials for SFP Iron-Delivery in Hemodialysis Patients More...
• Pfizer Inc. (PFE) Announces Positive Top-Line Results From the ORAL Start Phase 3 Study of Tofacitinib in Rheumatoid Arthritis More...
• FDA Requests Teleconference to Discuss Repros Therapeutics Inc. (RPRX) Phase 2 Protocol for Proellex® in the Treatment of Endometriosis Last Week of August More...
• Mindreading Hormone? A Better Judge of Character With Nasal Spray? University of Oslo Study More...
• Rejected Alzheimer's Drug Shows New Potential, Mount Sinai School of Medicine Study More...
• Brains are Different in People With Highly Superior Autobiographical Memory,University of California, Irvine Study More...
• Computer Scientists Present Smile Database, University of Amsterdam Study More...
• Brain Development Delayed in ADHD, National Institutes of Health (NIH) Study More...
• StemCells Inc. (STEM) Broadens HuCNS-SC® Patent Portfolio With Key Patent in Japan More...
• GeNO LLC Receives Two Additional Patents For Inhaled Nitric Oxide Drug Delivery More...
• Abon Announces CLOLAR® Patent Challenge More...
• GlaxoSmithKline (GSK) Shipping U.S. Flu Vaccine With New Strain Coverage Recommended for 2012-2013 More...
• Mersana Therapeutics, Inc. Raises $27 Million to Advance Antibody-drug Conjugates More...
• Ultragenyx Raises $15 Million Toward $30 Million Goal More...
• CytomX Therapeutics, Inc. Expands Series B Financing; Canaan PartnersJoins Syndicate More...
• CMC Biologics Acquires XOMA Corporation (XOMA)'s Bay Area Manufacturing Facility More...
• CytoDyn Announces Entry into Agreement With Progenics Pharmaceuticals, Inc. (PGNX) to Acquire PRO 140 More...
• Idenix Pharmaceuticals, Inc. (IDIX) Regains Drug Rights From Partner Novartis AG (NVS) More...
• PolyMedix Inc. (PYMX.OB) and University of Pennsylvania Collaborate to Develop New Class of Defensin-Mimetic Antimicrobial Compounds to Treat Malaria More...
• Furiex Pharmaceuticals, Inc. (FURX) Announces Closing of Priligy® Asset Transfer and License Agreements More...
• Oncobiologics Inc. Announces a Collaboration Agreement with XOMA Corporation (XOMA) to Utilize XOMA's Fully Human Antibody Libraries for Their Discovery Platform More...
• Anchor Therapeutics Enters Into Collaborative Research Agreement With Kyowa Hakko Kirin for its Pepducin Technology More...
• KV Pharmaceutical CEO Gets Hefty Raise, Despite All the Problems More...
• Soren Tulstrup to Lead Shire plc (SHPG) HGT's MPS Franchise More...
• Cytovance Biologics Inc. Announces Don Wuchterl as Senior Vice President of Manufacturing Operations More...
• Quick-Med Technologies (QMDT) Appoints Bernd Liesenfeld as President More...
• A.P. Pharma, Inc. (APPA) Appoints Robert Rosen to Its Board of Directors More...
• Bayer AG (BAY.F) Lifts Guidance, Provisions Weigh on Earnings More...
• Acura Pharmaceuticals, Inc. (ACUR) Announces Second Quarter 2012 Financial Results More...
• Agennix AG Reports Financial Results for Second Quarter and First Half of 2012 More...
• Amarin Corporation PLC (AMRN) to Report Second Quarter 2012 Financial Results and Host Conference Call on August 8, 2012 More...
• Acasti Pharma First Quarter Results More...
• Teva Pharmaceutical Industries Limited (TEVA) Sues Genzyme Corporation (GENZ) for Poaching Employees More...
• EU Antitrust Charge for Servier, Teva Pharmaceutical Industries Limited (TEVA), Others Over Generics More...
• Immunovative Inc. Announces the Retention of Winston & Strawn LLP as Its Legal Counsel More...
• Arena Pharmaceuticals, Inc. (ARNA) Transfers Diet Pill Application to Eisai Company, Ltd. (ESALY.PK) More...
• FDA Accepts NuPathe Inc. (PATH)'s Migraine Patch NDA Resubmission for Filing More...
• Ariad Pharmaceuticals, Inc. (ARIA) Announces Submission of New Drug Application for Ponatinib to the FDA More...
• Vertex Pharmaceuticals Incorporated (VRTX) Lowers Incivek View; New Drug Data Lifts Shares More...
• Nymox Pharmaceutical (NYMX) Reports Positive Results From Combined Statistical Analysis of Long Term Follow-Up Studies of BPH Drug More...
• Rockwell Medical Technologies (RMTI) Completes Patient Enrollment in Phase III Clinical Trials for SFP Iron-Delivery in Hemodialysis Patients More...
• Pfizer Inc. (PFE) Announces Positive Top-Line Results From the ORAL Start Phase 3 Study of Tofacitinib in Rheumatoid Arthritis More...
• FDA Requests Teleconference to Discuss Repros Therapeutics Inc. (RPRX) Phase 2 Protocol for Proellex® in the Treatment of Endometriosis Last Week of August More...
• Mindreading Hormone? A Better Judge of Character With Nasal Spray? University of Oslo Study More...
• Rejected Alzheimer's Drug Shows New Potential, Mount Sinai School of Medicine Study More...
• Brains are Different in People With Highly Superior Autobiographical Memory,University of California, Irvine Study More...
• Computer Scientists Present Smile Database, University of Amsterdam Study More...
• Brain Development Delayed in ADHD, National Institutes of Health (NIH) Study More...
• StemCells Inc. (STEM) Broadens HuCNS-SC® Patent Portfolio With Key Patent in Japan More...
• GeNO LLC Receives Two Additional Patents For Inhaled Nitric Oxide Drug Delivery More...
• Abon Announces CLOLAR® Patent Challenge More...
• GlaxoSmithKline (GSK) Shipping U.S. Flu Vaccine With New Strain Coverage Recommended for 2012-2013 More...
• Mersana Therapeutics, Inc. Raises $27 Million to Advance Antibody-drug Conjugates More...
• Ultragenyx Raises $15 Million Toward $30 Million Goal More...
• CytomX Therapeutics, Inc. Expands Series B Financing; Canaan PartnersJoins Syndicate More...
• CMC Biologics Acquires XOMA Corporation (XOMA)'s Bay Area Manufacturing Facility More...
• CytoDyn Announces Entry into Agreement With Progenics Pharmaceuticals, Inc. (PGNX) to Acquire PRO 140 More...
• Idenix Pharmaceuticals, Inc. (IDIX) Regains Drug Rights From Partner Novartis AG (NVS) More...
• PolyMedix Inc. (PYMX.OB) and University of Pennsylvania Collaborate to Develop New Class of Defensin-Mimetic Antimicrobial Compounds to Treat Malaria More...
• Furiex Pharmaceuticals, Inc. (FURX) Announces Closing of Priligy® Asset Transfer and License Agreements More...
• Oncobiologics Inc. Announces a Collaboration Agreement with XOMA Corporation (XOMA) to Utilize XOMA's Fully Human Antibody Libraries for Their Discovery Platform More...
• Anchor Therapeutics Enters Into Collaborative Research Agreement With Kyowa Hakko Kirin for its Pepducin Technology More...
• KV Pharmaceutical CEO Gets Hefty Raise, Despite All the Problems More...
• Soren Tulstrup to Lead Shire plc (SHPG) HGT's MPS Franchise More...
• Cytovance Biologics Inc. Announces Don Wuchterl as Senior Vice President of Manufacturing Operations More...
• Quick-Med Technologies (QMDT) Appoints Bernd Liesenfeld as President More...
• A.P. Pharma, Inc. (APPA) Appoints Robert Rosen to Its Board of Directors More...
• Bayer AG (BAY.F) Lifts Guidance, Provisions Weigh on Earnings More...
• Acura Pharmaceuticals, Inc. (ACUR) Announces Second Quarter 2012 Financial Results More...
• Agennix AG Reports Financial Results for Second Quarter and First Half of 2012 More...
• Amarin Corporation PLC (AMRN) to Report Second Quarter 2012 Financial Results and Host Conference Call on August 8, 2012 More...
• Acasti Pharma First Quarter Results More...
• Teva Pharmaceutical Industries Limited (TEVA) Sues Genzyme Corporation (GENZ) for Poaching Employees More...
• EU Antitrust Charge for Servier, Teva Pharmaceutical Industries Limited (TEVA), Others Over Generics More...
• Immunovative Inc. Announces the Retention of Winston & Strawn LLP as Its Legal Counsel More...
• Vitrolife's Subsidiary in the USA has Been Sued More...
0 comments